Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Dec;21(12):867–875. doi: 10.1097/FPC.0b013e32834cebc6

Table 3.

Odds ratios of atherosclerosis associated with clinical and serum factors.

Factor1 Comparison Units n Odds Ratio 95% CI P-Value
Age 5 years 200 1.22 (1.04,1.43) 0.0138
Gender Male vs Female 200 4.13 (2.29,7.46) <0.0001
Smoker Ever vs Never 200 2.45 (1.38,4.31) 0.0023
LDLGroup Elevated vs Normal 197 10.08 (3.75,27.08) <0.0001
HDLGroup Low vs Normal 196 2.66 (1.47,4.82) 0.0012
Triglyceride Abnormal vs Normal 97 6.57 (2.70,15.97) 0.0267
BMI 5 kg/m2 198 0.75 (0.59,0.95) 0.018
POaseNa2 150 U/L 199 0.78 (0.62,0.98) 0.0326
DZOaseNa2 1000 U/L 199 0.89 (0.80,0.99) 0.0346
POase2 15 U/L 199 0.92 (0.85,0.99) 0.0334
DZOase2 1000 U/L 199 0.85 (0.75,0.97) 0.0169
PhAc2 1000 U/L 199 0.89 (0.82,0.98) 0.0128
1

Factors that were included in study but not found significant at p≤ 0.05 included race, hypertension, diabetes, family history, waist circumference, total cholesterol group, LDL/HDL ratio, genotype, DZOaseNa/POaseNa ratios, and DZOase/POase ratios

2

Activities of POaseNa, DZOaseNa, POase, DZOase, and hydrolysis of PhAc are expressed as micromoles substrate hydrolyzed per minute per liter of serum (U/L), means ± SD.